Author Shares An Overview of His Fiction Novel: A Profound Interview

The Girl with the Lightning Brain

Author Shares An Overview of His Fiction Novel: A Profound Interview

CHICAGO, ILLINOIS, UNITED STATES OF AMERICA, December 28, 2018 /EINPresswire.com/ — “The book would be of interest to anyone who likes science fiction or action adventure, or also socio-political thriller,” Ratza utters as he presents the book information to the readers. In a profound interview during the BookExpro America 2018, the author shares more about the first instalment of his book series.

The Girl With The Lighting Brain is a literary fiction that can be read on six different levels, wrapped in an action-adventure thriller that explains the life of the main character, Electra “Kit” Kitter, together with all the well-developed characters in the story. The book explores the challenges that the country is facing and the ways to deal with these problems. Three of six books have already been written.

The author offers a bonus, a series of games for the readers to enjoy and learn from. Everyone is invited to watch the interview through https://youtu.be/udoD-g9_LNI, take a glimpse of the authors published book and get ready for a life-changing experience!

About the Author:
Author Cliff Ratza characterizes himself a "simple scholar," having parlayed multiple degrees (math and physics, business and computer science) into a business career spanning numerous jobs, companies, and industries. He grew up in Chicago, graduating from top Illinois universities, then launched his business career. He returned to Chicago, where he teaches at several universities while continuing to work for corporations. He subsequently started a sales and marketing consulting business, and most recently added a writing career to his resume.

Cliff has written extensively throughout his career. He has published articles in four professional journals, writes copy for client Websites, and develops press releases or newsletters. He has already written three novels in his ground-breaking "Lightning Brain Series." The first, "The Girl with the Lightning Brain," is now available in print or e-book format at bookstores or online. Please visit www.authorcentrix.com or call 8885040951 for more details when you are ready to buy.

Cliff dedicates the series to readers everywhere and invites them to visit the "Lightning Brain" Website, www.lightningbrainseries.com, to learn more about the books or enter reader contests.

Product details
Paperback: 546 pages
Publisher: AuthorCentrix, Inc. (February 13, 2018)
Language: English
ISBN-10: 1641333316
ISBN-13: 978-1641333313
Product Dimensions: 6 x 1.2 x 9 inches

Book Availability:
Amazon – http://goo.gl/SABQ7R
Barnes & Noble – http://goo.gl/m5Fktp

Clifford Leonard Ratza
AuthorCentrix, Inc.
+1 888 504 0951
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Author Releases A Facebook Page for The Girl with the Lightning Brain

The Girl with the Lightning Brain

Author Releases A Facebook Page for The Girl with the Lightning Brain

CHICAGO, ILLINOIS, UNITED STATES OF AMERICA, December 28, 2018 /EINPresswire.com/ — The book entitled The Girl with the Lightning Brain authored by Clifford Ratza challenges readers to travel to the depth of their thoughts. As the extrapolation of the latest science commences, the unearthing of details from political intrigue, the rising of contemporary lifestyle – factors that give the twists in the life of Electra “Kit” Kitter. The book has undeniably reached its peak after its publication. From a self-published title, it has reached several sites and is now available for the readers.

The author has endeavored through the years to offer first-rate details about his books. Now the title reaches another milestone as it is now on social media. The readers can now be entertained through the book’s exclusive Facebook Fan Page account. Queries can now be easily raised and addressed.

Everyone is invited to visit the sites for The Girl with the Lightning Brain :

https://www.facebook.com/Cliff-Ratza-338182933350534/

amazon.com/author/cliffratza

https://twitter.com/Author_Cliff

About the Author:
Author Cliff Ratza characterizes himself a "simple scholar," having parlayed multiple degrees (math and physics, business and computer science) into a business career spanning numerous jobs, companies, and industries. He grew up in Chicago, graduating from top Illinois universities, then launched his business career. He returned to Chicago, where he teaches at several universities while continuing to work for corporations. He subsequently started a sales and marketing consulting business, and most recently added a writing career to his resume.

Cliff has written extensively throughout his career. He has published articles in four professional journals, writes copy for client Websites, and develops press releases or newsletters. He has already written three novels in his ground-breaking "Lightning Brain Series." The first, "The Girl with the Lightning Brain," is now available in print or e-book format at bookstores or online. Please visit www.authorcentrix.com or call 8885040951 for more details when you are ready to buy.

Cliff dedicates the series to readers everywhere and invites them to visit the "Lightning Brain" Website, www.lightningbrainseries.com, to learn more about the books or enter reader contests.

Product details
Paperback: 546 pages
Publisher: AuthorCentrix, Inc. (February 13, 2018)
Language: English
ISBN-10: 1641333316
ISBN-13: 978-1641333313
Product Dimensions: 6 x 1.2 x 9 inches

Book Availability:
Amazon – http://goo.gl/SABQ7R
Barnes & Noble – http://goo.gl/m5Fktp

Clifford Leonard Ratza
AuthorCentrix, Inc.
+1 888 504 0951
email us here
Visit us on social media:
Facebook
Twitter


Source: EIN Presswire

Lee Bressler points out distinctions between AI and automation

Lee Bressler

Financial services industry professional Lee Bressler addresses the importance of distinguishing between artificial intelligence and process automation.

NEW YORK , NEW YORK, USA, December 28, 2018 /EINPresswire.com/ — With machine learning and AI two incredibly hot topics throughout 2018 and going into 2019, Lee Bressler looks at the key differences between groundbreaking artificial intelligence and more straightforward process automation as he debunks a number of myths surrounding the technology.

"There has been much talk about the ways in which artificial intelligence could replace current workers in the not-too-distant future," says Bressler, an equity fund portfolio manager based in New York City.

Indeed, according to researchers at the University of Oxford, a collegiate research university in Oxford, England, as many as 47 percent of jobs in the United States could be at risk of replacement by artificial intelligence, robots, and other forms of automated technology by 2040.

According to Bressler, however, the threat may not be as real or as significant as it seems. "There's something of a misconception that artificial intelligence and associated technologies will lead to huge company layoffs and massive spikes in unemployment," he explains.

"While there is little doubt,"Lee Bressler continues, "that these technologies will ultimately replace certain job roles and tasks, the panic surrounding artificial intelligence is largely unnecessary."

First and foremost, people must take into consideration the difference between artificial intelligence and more straightforward task automation, says Bressler. "There needs to be more clarity between what constitutes artificial intelligence and what simply amounts to automation," he explains, "whereby which automation employs technology solely to tackle low level, often highly repetitive tasks, which may or may not currently be handled by human workers."

Artificial intelligence, on the other hand, according to Lee Bressler, is much smarter. "Artificial intelligence works to pull together new insights, identify patterns, predict behaviors, and enhance customer experiences, among other things," he explains, "but still relies heavily on data engineers and data scientists to maintain and refine the necessary algorithms."

He continues, "While artificially intelligent solutions are capable of handling vast amounts of data more accurately and more efficiently than a human counterpart, as well as tackling many other tasks, they will always need intervention from humans."

Accordingly, Lee Bressler says that while automation will undoubtedly replace certain roles, increased efficacy of processes as a result will open up new roles, and create demand for those skilled and in a position to oversee such matters.

"Ultimately," he adds, wrapping up, "the true role of artificial intelligence right now, and in the immediate future, is to augment human capabilities and intelligence, and not simply to replace the

Chris Hinman
Web Presence, LLC
+1 757-880-3579
email us here


Source: EIN Presswire

Drawing Holds Clues to Better Long-Term Memory

After nine weeks, participants were five times more likely to remember words they had drawn than words they had written.

Drawing linked to improved retention of knowledge compared to writing

The person appears to automatically turn the act of drawing into long-term memory”

— Unnur Ottarsdottir

REYKJAVIK, ICELAND, December 28, 2018 /EINPresswire.com/ — It seems the kids who doodle and draw in their notebooks during class might be onto something.

In a study recently published in the journal ATOL: Art Therapy OnLine, 134 subjects were asked to draw the content of certain words and write other words down. Some participants recalled what they had written and drawn after three weeks, and others after nine weeks. In both cases, words that were drawn were more successfully recalled than words that were written. After three weeks, the median number was two to one in favour of drawn words. After nine weeks, that ratio grew to a staggering five to one in favour of drawing.

“The person appears to automatically turn the act of drawing into long-term memory,” says study author and art therapist Unnur Ottarsdottir. “This is the first time this type of research on such a long-term memory has been conducted worldwide prior to now, as far as we are able to tell, and the findings are very intriguing.”

Ottarsdottir began practising and researching art therapy in the early 1990s. She has published, spoken and taught at conferences and universities around the globe on the subject. Not only is drawing more effective than writing at stimulating long-term memory, says Ottarsdottir, but it is also useful for processing and working through emotions. Ottarsdottir also conducted another related research study with five children who had experienced stress or trauma and had specific learning difficulties. The children drew pictures partly to memorize coursework material, but Ottarsdottir found indications that the drawing could also relate to processing of emotions associated with difficult or traumatic experiences.

“It appears that in drawing, the children often manage to express vulnerable and complex feelings more easily than they do when speaking,” says Ottarsdottir. “Art therapy theories and methods are important in order to understand this process, and we hope that we can learn more about how art making can help us make further breakthroughs in this area in future studies.”

Ottarsdottir is available for interviews about the study and its findings by clicking on the contact information included in this release. The full paper on the experiment, “Processing Emotions and Memorising Coursework through Memory Drawing,” was published in ATOL: Art Therapy OnLine, and can be viewed at http://journals.gold.ac.uk/index.php/atol/article/view/486/pdf.

###

Unnur Ottarsdottir
Art Therapy Ottarsdottir
+354 867 0277
email us here
Visit us on social media:
Facebook

Scientist Reveals Easy Way to Improve Memory 500%


Source: EIN Presswire

Device On The Market Reduces Dental Pain: New Research

Visit the dentist without pain, with Buzzy!

We're starting to understand the link between oral and overall health. Visiting the dentist is key to good health. This new study shows Buzzy may help patients who fear going to the dentist.”

— Amy Baxter MD, CEO & Chief Medical Officer, Pain Care Labs

ATLANTA, GEORGIA, US, December 27, 2018 /EINPresswire.com/ — News Alert: Between 9% and 15% of Americans say they avoid going to the dentist, according to the Cleveland Clinic. The needle pain and fear behind good oral health are often rooted in a negative childhood experience in the dentist's chair. New research about a device created by the industry leader in local pain relief may change that.

A new study out this month demonstrates a fast, inexpensive device that is widely used for intramuscular injections in hospitals and homes may conquer those early negative experiences. Buzzy, manufactured by Pain Care Labs, is a vibrating ice pack used in over 5,000 hospitals and clinics to physically block needle pain. Last year, the company won the prestigious Frost & Sullivan "Local Pain Relief" technology leader award. In large independent studies, Buzzy has been proven equivalent to both the leading topical anesthetic and virtual reality.

The study randomized sixty (60) children, aged seven (7) years old, who needed an injection on both sides of the mouth. One side got standard care, while the other side used Buzzy's cold and vibration in addition to the control protocol. Heart rate, the dentists' rating of pain on a movement scale, and the kids themselves all demonstrated significantly lower pain on the side of the mouth with Buzzy.

"Cold and vibration are potent pain relievers for adults," noted Pain Care Labs' CEO Amy Baxter MD. "This study is important because it shows that even for the hardest patient group–kids injected in a dentist's chair–Buzzy's cold and vibration works for needle pain."

Patients in the Buzzy group did significantly better in all domains: reduced discomfort; lower heart rate; lower pain score. The authors observed Buzzy to be effective in reducing discomfort and fear in children undergoing infiltration dental analgesia.

"Our Buzzy device is FDA-cleared to control pain associated with injections," says Dr. Amy Baxter. "We know dentists also use our technology to address fear. We are hopeful that studies like this one will persuade other dental professionals to add our simple, affordable, reusable device to their existing menu of pain relief options."

About Pain Care Labs

Founded in 2006 by pediatric emergency doctor and pain researcher Amy Baxter MD FAAP FACEP, Pain Care Labs is on a mission to eliminate unnecessary pain. Using the physiologic technique of “gate control”, the devices block pain by stimulating the motion nerves (like TENS units) and cold nerve feedback system. Instead of electric shocks, Pain Care Labs determined the frequency that naturally stimulates the motion nerves with comfortable vibration. Unique intense ice packs reduce inflammation and add a powerful inhibitory pain relief called Descending Noxious Inhibitory Control. The company’s award-winning first device, Buzzy for Shots, created a new category of pain reliever. In 2017 the company was awarded the “Industry Leader in Local Pain Relief” from Frost & Sullivan. Buzzy is used worldwide and has blocked pain from over 31 million needles. VibraCool is used for athletic and post-operative pain. New DuoTherm Vibrating Back Pain reliever will be introduced at CES this January. See other projects and company information at http://www.paincarelabs.com.

Jennifer Tipping
Pain Care Labs
+1 877-805-2899
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Buzzy at the dentist, Brazil


Source: EIN Presswire

eQuine Holdings discloses 8% stake in AngioSoma (SOAN)

eQuine Holdings has filed a form 13D with the SEC disclosing an 8% stake in AngioSoma (SOAN), after announcing its LOI for the acquisition of Diabetes Relief

AngioSoma (OTCBB:SOAN)

DALLAS, TEXAS, USA, December 27, 2018 /EINPresswire.com/ — eQuine Holdings, a Class II Multi-Family Office, has disclosed an eight percent (8%) equity stake in AngioSoma (SOAN)

On December 17, 2018 AngioSoma announced a Partially Binding Letter of Intent to acquire Diabetes Relief.

A copy of SEC form 13D can be found at: https://www.sec.gov/Archives/edgar/data/1502152/000091228218000168/angiosoma-atwood13d_122618.htm

About eQuine Holdings, LLC – eQuine Holdings, LLC is a Class II multi-family office, responsible for managing the day to day operations of various interests in private and public companies. For the past decade, ultra-high net worth families have entrusted eQuine to advise them on wealth preservation & growth, tax advisement, risk mitigation and legacy generational planning.

About AngioSoma (SOAN) – AngioSoma is a clinical stage biotechnology company focused on improving the effectiveness of current standard-of-care treatments related to pharmaceutical or endovascular interventions. Our “end to end” solution will provide interventional radiologists, cardiologists, and internal medicine physicians with both pharmaceutical and or endovascular interventional options prior to infarction or critical limb ischemic events, stabilizing or reversing the atherosclerotic disease. For pharmaceutical stabilization, our Liprostin™ product for treatment of peripheral artery disease (“PAD”) completed preliminary U.S. Food and Drug Administration (“FDA”) required Phase I and Phase II clinical trials successfully and is entering Phase III prior to approval. For long term preventative measures, our Transdermal PGE-1 Patch will provide ongoing treatment for chronic cardiovascular disease by delivery of PGE-1 or Liprostin™ through the skin.In all, we have a robust product pipeline from 20+ years of research and development, with existing patents, provisional patents, formulations, and trademarks from previously successful products

About Diabetes Relief – Diabetes Relief licenses medical facilities for the treatment of metabolic disorder, specializing in diabetes, for the use of patented protocols, processes, and intellectual property. Treatments are individualized to a patient’s condition and metabolic state. Diabetes Relief, through providing thousands of treatments, has seen vast improvements for patients. Clinical trials for FDA approval of Liprostin™, that is intended to treat Peripheral Artery Disease, or PAD, may be facilitated by the acquisition.

NOTICE REGARDING FORWARD LOOKING STATEMENTS

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.

Although we believe that these statements are based on reasonable assumptions, they are subject to numerous factors, risks and uncertainties that could cause actual outcomes and results to be materially different from those indicated in such statements, including the risks described in our Annual Report on Form 10-K as filed with the Securities and Exchange Commission. Except as required by law, we undertake no obligation to update or revise any forward-looking statements to reflect changed assumptions, the occurrence of anticipated or unanticipated events, new information or changes to future results over time or otherwise.

Media Relations
eQuine Holdings, LLC
+1 907-738-8458
email us here
Visit us on social media:
Facebook
LinkedIn


Source: EIN Presswire

BLOCKCHAIN INTEGRATION INTO BIG BUSINESS: HOW IT WORKS

NY, NEW YORK, UNITED STATES, December 27, 2018 /EINPresswire.com/ — Blockchain technology has come into our modern life quickly and confidently. The data hashing technology in private networks is made as the mechanism providing the record and encryption of any transaction between two bodies in a permanent and provable way. Truth, but as long as companies, entrepreneurs and investors are afraid of new technologies like blockchain or cryptocurrency and do not follow the technological trends, the digital economy will not reach its top.

Anyway, blockchain always develops and finds its admirers. The mayor of the largest metropolis of South Korea has announced about his intention to make Seoul a “smart” city based on the blockchain technology. The strategy called Blockchain Urban Plan (2018-2022) involves 14 public services of 5 industries, for instance, human services, transport, certificate issuing, voting system, and donations management.
According to the opinions of the banking sector representatives, the banks sharply react to the technologies as the new market is not regulated. That is why the banks are not ready to integrate the cryptographic economy into the banking sector because the main features of blockchain such as anonymity and decentralization are at variance with the initial idea of the bank.

In spite of it, the blockchain payment service CLA group conducted the press release (November 28, 2018) where one of the largest investment banks Goldman Sachs and multinational investment banking enterprise Morgan Stanley were announced to be among the users of this blockchain-based service.

Apart from that, the holding company JPMorgan, the financial corporation Citigroup and financial services company Barclays become the members of CLA Group. The financial institution of the foreign exchange market (FX) reaches $5 trillion daily and is meant to be the first FX settlement service running on the base of the blockchain technology.
The intention to accept blockchain in the main financial mechanism of both companies will lead to improvement of payment netting process. The reduced costs, the increase of operation efficiency, the business growth and so on will gain their support throughout the blockchain technology usage. There is nothing strange that these investment giants such as Goldman Sachs and Morgan Stanley are going to launch the products related to Bitcoin.
In addition to Goldman Sachs and Morgan Stanley news, the blockchain technology has not gone past the largest online retailer in the world – Amazon. On the base of blockchain, this tech giant launches a service in order to provide the clients with easy development of their blockchain networks with no difficulties and costs during the creation of their own platform.
Recently created the Amazon Managed Blockchain is known to be a service providing reliable, manageable, and scalable blockchain networks. The Amazon users are able to build the platform using the open source frameworks – either Ethereum or Hyperledger Fabric.

The Amazon Managed Blockchain is another style of online trading and web services. The platform powers a lot of websites and media providers such as Netflix platform. What is more, the Amazon Quantum Ledger Database, which was created as the applications’ data guard, works as a ledger database meeting the demands of many users. The organizations use QLDB for recording and analyzing the history of economic and financial activity. With QLDB, data can be neither altered nor deleted. As a result, the history of the applications’ data is saved and owned by the central trusted authority. The people who are interested in this service are able to sign up and create a blockchain network if they are approved.

Despite the fact that the cryptocurrency sector which is known to be the most popular area for the blockchain technology usage experiences hard times, blockchain remains to be widespread and popular around the world. With its help, it will be more than possible to automate most of the business processes which are necessary for business activity. Then, in the view of the analytical and research company COR Index INC (New York, US) that professionally deals with studying of data and information about blockchain projects and cryptocurrency at all, large business companies that are leaders in their industries cannot ignore and deny the modern technologies such as blockchain. 2018 has shown that the use of blockchain technology became a necessity. For some many industries, blockchain is meant to be a priority goal for its integration into their business processes.

Artem Baykov
COR Index inc
+1 9292165387
email us here
Visit us on social media:
Twitter


Source: EIN Presswire

Vein911® Vein Treatment Centers Medical Director Elected Fellow of the American College of Radiology

Vein911® Vein Treatment Centers announced that Medical Director and CEO,Christopher Pittman,M.D.,has been elected a Fellow of the American College of Radiology

I am humbled, honored and excited to be nominated and elected a Fellow of the American College of Radiology”

— Dr. Chris Pittman, CEO of Vein911® Vein Treatment Centers

TAMPA, FL, UNITED STATES, December 27, 2018 /EINPresswire.com/ — Vein911® Vein Treatment Centers announced today that Medical Director and CEO, Christopher Pittman, M.D., DABR, FACPh has been elected a Fellow of the American College of Radiology (ACR) — one of the highest honors the ACR can bestow on a member. Fellowship symbolizes exceptional achievement in the fields of diagnostic radiology, interventional radiology, nuclear medicine, radiation oncology, and/or medical physics. ACR Fellows have distinguished themselves through one or more domains: service to the ACR and/or organized radiology/medicine; outstanding teaching of radiology; and/or significant scientific or clinical research in radiology and/or significant contributions to the literature. Only 10 percent of College members have been awarded this honor. Following a convocation ceremony to be held May 19, 2019 at the ACR Annual Meeting, newly elected Fellows may place FACR after their name to acknowledge the accomplishment.

Christopher Pittman, M.D., DABR, FACPh is a nationally recognized expert and thought leader on health care policy and politics, medical economics, and health information technology. He is Medical Director and CEO of Vein911® Vein Treatment Centers and Managing Director of Health Performance Specialists. Dr. Pittman serves on the Board of Directors of the American College of Phlebology (ACPh) and is the ACPh Delegate to the American Medical Association. He previously served on the Executive Committee of the ACPh Foundation, the Board of Governors of the Florida Medical Association, and is Past President of the Florida Medical Association Political Action Committee (FMA PAC) and Past President of the Hillsborough County Medical Association.

Dr. Pittman was recently elected a Fellow of the American College of Phlebology. Fellows of the American College of Phlebology (FACPh) are recognized for their substantial commitment and contribution to the specialty of venous disease treatment and care; shown through volunteerism, authored publications, education, years of practice, leadership and other qualifications that lead to the advancement of vein care.

“I am humbled, honored and excited to be nominated and elected a Fellow of the American College of Radiology,” said Dr. Chris Pittman, Medical Director and CEO of Vein911® Vein Treatment Centers.

About Vein911® Vein Treatment Centers
Vein911® is a leading provider of both medical and cosmetic vein care including varicose veins, ankle swelling, restless legs, night cramps, venous leg ulcers, and cosmetically disturbing veins of the hands, face and legs. Our world-class vein treatment centers offer state of the art technology within elegant and comfortable surroundings and a family atmosphere. Our non-surgical medical procedures include VenaCure EVLT Endovenous Laser Treatment, Venefit procedure using ClosureFast Endovenous Radiofrequency Ablation (RFA) and Ultrasound-Guided Foam Sclerotherapy which is the future of vein care available today at Vein911®. Our cosmetic procedures include Visual Sclerotherapy, the gold standard treatment for spider veins, and VeinGogh, an immediately effective treatment for facial veins. Vein911® is the varicose vein and spider vein treatment center of choice for physicians and their patients who are experiencing vein disease. Our vein treatment centers are conveniently located throughout the Tampa Bay area and are led by board-certified vein care specialist physicians.

Douglass Pace
Vein911 Vein Treatment Centers
+1 855-834-6911
email us here


Source: EIN Presswire

Chiropractic ABN's

“Buddy Up with The Best” Est. 1994 ®

Learn how to properly complete a Chiropractic ABN.

MINNEAPOLIS, MINNESOTA, USA, December 25, 2018 /EINPresswire.com/ — Billing Buddies releases a YouTube video on properly completing the Chiropractic ABN. Here's the transcription of our video. Click on the link to view the video.

Welcome to Billing Buddies YouTube and Podcast series.

In this episode, we will be discussing Chiropractic ABNs.

First, let’s define an ABN. An ABN is an abbreviation of a Medicare form known as the Advanced Beneficiary Notice. Medicare requires providers give an ABN to beneficiaries if the Medicare services they are proposing to deliver is suspected to not be covered by Medicare. If the service is statutorily excluded from the Medicare program, such as exams and therapies for chiropractic care, Medicare does not require an ABN be presented to the patient. Medicare only requires an ABN be presented on services that can be covered under the program such as CMT’s for chiropractic care.
It’s very important when receiving information that you can look up and research the data yourself. For this reason, whenever possible, Billing Buddies will share the source for you to review. The information from this presentation came from www.CMS.gov. You can type ABN in the upper right-hand corner of the screen and search for information on Advance Beneficiary Notices or ABN’s.

Now, let’s take a look at the form. There are several boxes to complete. You can see items A through J are to be completed by the provider and the patient. Let’s review the form.
Field A = Enter the Notifiers Information – This is the clinic and staff member presenting the ABN.
Field B = Enter the Patient’s Name
Field C = Enter the Patient’s Medicare Number
Field D = Enter the Service to be provided. In Chiropractic care, this would be the CMT. You could enter codes 98940 – 98942 in this field.
Field E = Enter the Reason Medicare may not pay. In Chiropractic care, the most common reason would be that the CMT was considered maintenance care. But, review your Local Coverage Determination from your carrier for a complete list.
Field F = Enter the estimated cost. If more than one service is listed in Box D, enter the estimated cost for all services.
Field G = All the fields on the ABN are important, but this one is especially important. Patient’s are required to pick one of the three options. The provider may not complete this portion of the form or it will invalidate the form.
Field H = This is a field where additional information may be provided.
Field I = This requires the patient or representative to sign the form. If a representative signs the form, have the representative write “representative” in parenthesis after his/her signature.
Field J = The patient or representative must date the form when signed.

That completes our ABN video. Thank you for watching. Please subscribe to our channel and like our videos. Also, please comment if you would like other videos presented and suggestions on topics.
Billing Buddies has been assisting providers since 1994 and offers billing services, training and consulting. For more information, call or text 612.432.2366 or email bonnie@billingbuddies.com.

Bonnie J. Flom
Billing Buddies
+1 612-432-2366
email us here
Visit us on social media:
Facebook
Twitter
Google+
LinkedIn

Chiropractic ABN’s


Source: EIN Presswire

Scientific Scholar is partnering with Indian Dental Association as their consultant

Logo of JIDA

Publisher of Prestigious Scientific Journals

Scientific Scholar

Scientific Scholar a international publisher takes on the role of consultants to Indian Dental Association

Indexation of a journal is considered a reflection of its quality. Indexed journals are considered to be of higher scientific quality as compared to non-indexed journals”

— unknown

MUMBAI, MAHARASHTRA, INDIA, December 22, 2018 /EINPresswire.com/ — Scientific Scholar (https://scientificscholar.com) is partnering with Indian Dental Association as their consultant, advising them on various aspects of journal publication for Journal of Indian Dental Association (JIDA).

The Journal of the Indian Dental Association (JIDA) (http://publication.ida.org.in/IndexMain.htm#/about?CatId=91) is a peer-reviewed scientific journal on original research articles exclusively designed for clinical practitioners. It provides a platform for eminent dentists to publish their research and evidence-based findings in different fields of dentistry. It presents research work carried out, nationally and internationally in different specialties of dentistry. The focus is mainly on research and clinical trials on new procedures and techniques, dental materials, instruments, cosmetic and restorative materials, clinical studies and reviews on various dental diseases and their treatment.
It’s a complete evidence based informative guide for the dental practitioners, academicians and research scholars.

Scientific Scholar will be advising the JIDA on its compliance with all the rules and regulations required for JIDA to be Indexed in PubMed. This is the special service that Scientific Scholar (https://scientificscholar.com) offers on special request.

Scientific Scholar publishes very prestigious journals such as American Journal of Interventional Radiology (https://americanjir.com) and American Journal of Sonography (https://americanjs.com). Scientific scholar has complete inhouse facilities from designing journal website, manuscript management system, copyediting, page layout, printing, distribution and Indexing. We offer every service required for a successful journal publishing.

Scientific Scholar founders have an extensive academic and publication experience and has a very skilled and professional team. The Scientific Scholar has its own manuscript management platform. The platform mainly uses Drag and Drop functionality to accomplish its tasks. Its intuitive and has a short learning curve. Scientific Scholar can also license their manuscript management system to other journals and publishers.

Vikram Dogra
Scientific Scholar
+1 5852085337
email us here
Visit us on social media:
Twitter
Google+
LinkedIn


Source: EIN Presswire